Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Európska únia - španielčina - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - antígenos de superficie del virus de la gripe (hemaglutinina y neuraminidasa) de la cepa a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacunas - inmunización activa contra el subtipo h5n1 del virus influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Európska únia - španielčina - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptina, metformin hidrocloruro - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

CERTICAN ® 075 mg Kuba - španielčina - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

certican ® 075 mg

novartis pharma stein ag. - everolimus - comprimido - 0,75 mg

AFINITOR® 25 mg Kuba - španielčina - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

afinitor® 25 mg

novartis pharma stein ag. - everolimus - comprimido - 2,5 mg

Diovan 80 Kuba - španielčina - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

diovan 80

novartis pharma stein ag, suiza.novartis farmacéutica s.a., españa. - valsartán - comprimido recubierto - 80,0 mg

AFINITOR 2 5 mg Kuba - španielčina - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

afinitor 2 5 mg

novartis pharma stein ag, stein, suiza. novartis pharma ag, basel, suiza. - everolimus - tableta - 2,5 mg

AFINITOR 5 mg Kuba - španielčina - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

afinitor 5 mg

novartis pharma stein ag, stein, suiza. novartis pharma ag, basel, suiza. - (everolimus) - tableta - 5,0 mg

METHERGIN 0,125 mg GRAGEAS Venezuela - španielčina - Instituto Nacional de Higiene

methergin 0,125 mg grageas

novartis de venezuela, s.a. - maleato de metilergometrina - gragea - 0,125 mg (a3)

METHERGIN 0,2 mg/ml SOLUCION INYECTABLE Venezuela - španielčina - Instituto Nacional de Higiene

methergin 0,2 mg/ml solucion inyectable

novartis de venezuela, s.a. - hidrogenomaleato de metilergometrina - solucion inyectable - 0,2 mg/ml ( a9)

JAKAVI 15 mg COMPRIMIDOS Venezuela - španielčina - Instituto Nacional de Higiene

jakavi 15 mg comprimidos

novartis de venezuela, s.a. - ruxolitinib - comprimidos - 15 mg